Well Woman

A new survey highlights gender differences in knowledge and attitudes toward GLP-1/GIP receptor agonists.

A new study found that routine mammography significantly reduces late-stage diagnoses and mortality in women aged 70 years and older.

A new study finds that Black women living in economically disadvantaged neighborhoods face significantly higher breast cancer mortality rates.

Women with prior pre-eclampsia develop cardiovascular (CV) risk factors nearly a decade earlier, prompting calls for earlier and regular CV screening.

A new study from Intermountain Health reveals that while disparities in heart disease outcomes between men and women are shrinking, women still face unique risks and challenges in diagnosis and treatment.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study found that diet, exercise, and other health factors have a greater impact on heart disease risk in women than in men, highlighting the need for gender-specific prevention strategies.

A nurse-led intervention increased HPV vaccination rates among Hispanic adolescents in a rural North Carolina clinic, according to research presented at the 2025 NAPNAP conference.

A new artificial intelligence model analyzing electrocardiograms helps identify female patients at higher risk for heart disease, offering earlier detection and more personalized treatment.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.

A new study suggests that propranolol, a beta blocker used for migraine prevention, is linked to a reduced risk of ischemic stroke in women with migraine.

A recent study found that a single dose of intravenous iron in the third trimester is superior to oral iron in reducing anemia rates in pregnant women, ensuring better outcomes for mother and baby.

A new study finds that brief, incidental bursts of vigorous activity significantly reduce cardiovascular event risk, especially in middle-aged women.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study introduces the COronary Risk Score in WOmen, improving the prediction of major adverse coronary events in women and addressing gender gaps in cardiovascular research.

A study found that migraine-related disability worsens health-related quality of life, with gender-specific differences, particularly affecting women with mild disability.

A meta analysis highlights how kinesiotherapy post-breast cancer surgery may significantly improve patient quality of life.

HPV vaccination in Brazil led to significant reductions in genital warts and cervical precancer hospitalizations, especially among those under 20 years of age.

Learn about how women face unique risk factors of cardiovascular conditions compared to men, and how new screening methods such as breast arterial calcification can protect these patients.

In a recent study, non-Hispanic Black patients were less likely to receive guideline-concordant care and had greater mortality rates, highlighting the potential for improved survival by optimizing receipt of timely care.

Reunion Neuroscience is enrolling patients in its phase 2 RECONNECT trial to assess a single-dose synthetic psychedelic to treat the depressive symptoms of PPD.

From screening, to workup and treatment, find out how to provide the best course of action for your pregnant patients with anemia.

In a recent study, approximately half of infective endocarditis cases were women who inject drugs, despite only one-third of people who inject drugs being women.

In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.

Matthew Nudy, MD, discusses his team's findings on hormone therapy and cardiovascular effects at the 2024 Annual Meeting of the Menopause Society.

Learn how self-advocacy, preparation, and collaboration with doctors can help women gain control over their health and live more fully, free from stigma and shame.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, 23% of patients with breast arterial calcifications on a mammogram had atherosclerotic cardiovascular disease, vs 13.9% without.

Wendie Berg, MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, the prevalence of Alzheimer’s disease was significantly increased among women with prior trauma.